Transition of Care in CKD (TC-CKD)
Transition of Care in CKD (TC-CKD)
批准号:
8865625
负责人:
STEVEN J JACOBSEN
金额:
$56.92万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-10 至 2019-03-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisAgeAnemiaAreaArteriovenous fistulaBlood PressureBlood VesselsBone DiseasesCaliforniaCaringCategoriesCathetersChronic Kidney FailureClinicalComorbidityComorbidity IndexDataDatabasesDecision MakingDemographic AgingDialysis procedureDiseaseDisease ProgressionEnd stage renal failureEventFigs - dietaryFrequenciesHealthHealthcare SystemsHeart failureHemodialysisHome environmentHospitalizationHypothyroidismInterceptKidney DiseasesKidney TransplantationKnowledgeLaboratoriesLinkLiver diseasesMalnutritionMeasuresMetabolic acidosisMineralsModalityObesityOutcomePatientsPeritonealPeritoneal DialysisPreparationProteinsRenal Replacement TherapyReportingResearch PersonnelResearch Project GrantsSpeedStagingSystemTestingTimeTransplant RecipientsTransplantationUncertaintyUnited States Department of Veterans AffairsVeteransWithdrawalbasecaregivingcohortcostdemographicsdiabetes controlend of lifefrailtyglycemic controlhypercholesterolemiahypertension treatmentinnovationlongitudinal databasemortalityprospectivetrendwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In patients with very-late-stage non-dialysis dependent (NDD) CKD (eGFR <25 ml/min/1.73 m2) the optimal transition of care to renal replacement therapy (RRT, i.e., dialysis or transplantation) is not known. Major uncertainty and significant knowledge gaps have persisted pertaining to differential or individualized transitions of care across different age and demographics and different pre-RRT comorbid conditions and events in several key areas including: (1) the best timing for RRT initiation; (2) the optimal RRT
type (dialysis vs. transplant); and in the case of dialysis, the best modality (hemo- vs. peritoneal), format (in-center vs. home), frequency (daily vs. infrequent) and vascular access preparation; (3) the post-RRT impact of pre-RRT comorbid conditions and events including blood pressure and glycemic control, acute kidney injury episodes, and management of CKD specific conditions such as anemia and mineral disorders; and (4) the impact of the above pre-RRT conditions on end-of-life care and decision-making. Given the enormous changes occurring in our health care system and given the high costs of dialysis therapy with persistently poor outcomes, there is an urgent need to answer these important questions related to CKD transitions to RRT. Given the inherent limitations of the USRDS that lacks most core data prior to the RRT transition intercept, we propose a highly innovative linkage approach between the USRDS and two exceptionally rich and large longitudinal databases of very-late-stage NDD-CKD patients, i.e., the national (entire US) Veterans Affairs (VA) database and the regional (Southern California) Kaiser Permanente (KPSC) database, each consisting of millions of people including over 20,000 NDD-CKD patients with eGFR<25 ml/min who transitioned to RRT over the 5-year period 1/1/2008-1/1/2013. These cohorts will also provide annual linkage to projected (2013- 2016) data from over 4,000 incident ESRD patients including several hundred kidney transplant recipients each year for 4 years, hence adding over 16,000 linked patients who will transition to RRT. We hypothesize that (1) a pre-RRT data-driven individualized approach to the transition of care into RRT in very-late-stage CKD is associated with more favorable outcomes including greater survival, fewer hospitalizations and reduced costs, if the decision is based on pre-RRT factors such as clinical and lab variables including the CKD progression rate and comorbid conditions combined with demographics, and (2) that a scoring system derived from these pre-RRT data can determine the timing, preparation and modality of RRT to achieve better outcomes. Upon linking the national VA and regional KPSC data with the USRDS to identify those who have transitioned to dialysis or transplantation, we will examine the predictors of short- (first 6 months) and long-term mortality, hospitalizations and costs by generating pertinent de novo variables including pre-RRT eGFR slope, laboratory data trends and comorbidity indices; and these pre-RRT variables on >36,000 transitioned patients will be linked and reported annually and eventually become available to the USRDS to share with researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transition of Care in CKD (TC-CKD)
-
批准号:9273515
-
项目类别:
-
资助金额:$55.4万
-
财政年份:2014
-
负责人:STEVEN J JACOBSEN
-
依托单位:
Transition of Care in CKD (TC-CKD)
-
批准号:8707161
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2014
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM: THE OLMSTED COUNTY STUDY
-
批准号:7206118
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2005
-
负责人:STEVEN J JACOBSEN
-
依托单位:
Natural History of Prostatism: The Olmsted County Study
-
批准号:7042331
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2003
-
负责人:STEVEN J JACOBSEN
-
依托单位:
Trainee-Focusted Training for Research Integrity
-
批准号:6665297
-
项目类别:
-
资助金额:$13.73万
-
财政年份:2002
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
-
批准号:6524347
-
项目类别:
-
资助金额:$51.69万
-
财政年份:2000
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
-
批准号:6381946
-
项目类别:
-
资助金额:$65.76万
-
财政年份:2000
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
-
批准号:6256421
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2000
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
-
批准号:6777034
-
项目类别:
-
资助金额:$55.38万
-
财政年份:2000
-
负责人:STEVEN J JACOBSEN
-
依托单位:
NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY
-
批准号:6647624
-
项目类别:
-
资助金额:$74.94万
-
财政年份:2000
-
负责人:STEVEN J JACOBSEN
-
依托单位:
ROCHESTER EPIDEMIOLOGY PROJECT
-
批准号:6534406
-
项目类别:
-
资助金额:$43.38万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
ROCHESTER EPIDEMIOLOGY PROJECT
-
批准号:6199495
-
项目类别:
-
资助金额:$42.1万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
ROCHESTER EPIDEMIOLOGY PROJECT
-
批准号:6649861
-
项目类别:
-
资助金额:$44.46万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
Rochester Epidemiology Project
-
批准号:6983530
-
项目类别:
-
资助金额:$58.2万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
ROCHESTER EPIDEMIOLOGY PROJECT
-
批准号:6374863
-
项目类别:
-
资助金额:$42.21万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
ROCHESTER EPIDEMIOLOGY PROJECT
-
批准号:6792784
-
项目类别:
-
资助金额:$45.51万
-
财政年份:1995
-
负责人:STEVEN J JACOBSEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: